Amy Arrow

This inventor holds 14 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Oligos Etc. Inc., Lakewood Amedex, Inc., Chemgenes Corporation. Active years: 1998-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amy Arrow. Retrieved from https://idiyas.com/inventor/amy-arrow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 57.1

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 584(Granted Patents)

Location History:

Newtown, CT (US) (1998 - 2000)
Bethel, ME (US) (1999 - 2017)

Company Filing History:

Lakewood Amedex, Inc.

patents

1 out of 21

Chemgenes Corporation

5. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2017

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9567584 - Oligonucleotide—containing pharmacological compositions and their use (2017-02-14),

2. 8916529 - Oligonucleotide-containing pharmacological compositions and their use (2014-12-23),

3. 8435960 - Devices for improved wound management (2013-05-07),

4. 8188259 - Oligonucleotide-containing pharmacological compositions and their use (2012-05-29),

5. 8183361 - Oligonucleotide-containing pharmacological compositions and their use (2012-05-22),

6. 7691996 - Three component chimeric antisense oligonucleotides (2010-04-06),

7. 7176191 - Antimicrobial compounds and methods for their use (2007-02-13),

8. 6958239 - Three component chimeric antisense oligonucleotides (2005-10-25),

9. 6627215 - Devices for improved wound management (2003-09-30),

10. 6211349 - Protonated/acidified nucleic acids and methods of use (2001-04-03),

11. 6211162 - Pulmonary delivery of protonated/acidified nucleic acids (2001-04-03),

12. 6015886 - Oligonucleotide phosphate esters (2000-01-18),

13. 5989912 - Three component chimeric antisense oligonucleotides (1999-11-23),

14. 5849902 - Three component chimeric antisense oligonucleotides (1998-12-15),

Title: The Innovative Contributions of Amy Arrow

Introduction

Amy Arrow is a prominent inventor based in Bethel, ME (US), known for her significant contributions to the field of pharmacology. With a total of 14 patents to her name, she has made remarkable advancements in the use of oligonucleotides for medical applications. Her work has paved the way for new therapeutic methods that benefit both humans and other mammals.

Latest Patents

Among her latest patents is the invention titled "Oligonucleotide-containing pharmacological compositions and their use." This invention relates to methods and compositions that contain oligonucleotides suitable for administration to humans and other mammals. The innovative nature of her work lies in the potential applications of these compositions in various medical treatments.

Career Highlights

Throughout her career, Amy has worked with notable companies such as Oligos Etc. Inc. and Lakewood Amedex, Inc. These experiences have allowed her to collaborate with leading experts in the field and further enhance her research and development efforts.

Collaborations

Amy has collaborated with esteemed colleagues, including Roderic M K Dale and Steven L Gatton. These partnerships have contributed to the success of her projects and the advancement of her inventions.

Conclusion

Amy Arrow's innovative work in the field of pharmacology, particularly with oligonucleotide-containing compositions, showcases her dedication to improving medical treatments. Her numerous patents and collaborations highlight her significant impact on the industry.

Profile summary based on public USPTO records.